Articles

Results 1 to 5 of 27


Termination, force majeure and frustration - international perspectives on the life sciences sector

China, France, Germany, United Arab Emirates, United Kingdom - April 17 2020 Click to open video Across our international offices, we're helping life science clients navigate the impact of COVID-19 on R&D, manufacturing and…

Paul Blakeway, Manja Epping, Laurence Lieberman, Nick Storrs

Recent legislative developments affecting biologics and biosimilars

European Union, USA - May 31 2019 Many of the top-selling drugs worldwide are biologics, and several companies are seeking to produce biosimilars to compete in these lucrative markets…

Manja Epping, Judith Krens, Matthew Royle

Recent developments in biosimilars settlements, market landscape and antitrust scrutiny

European Union, USA - March 21 2019 Many of the top-selling drugs worldwide are biologics, and several companies are seeking to produce biosimilars to compete in these lucrative markets…

Manja Epping, Judith Krens, Matthew Royle

The new French deferred prosecution agreement

France, USA - May 8 2018 Law n°2016-1691 (Sapin II) was adopted on 9 December 2016 and entered into force in the course of 2017. The purpose of Sapin 2 was to improve…

Mathias Kuhn

CJEU rules on prescription support software as a medical device

European Union, France - March 15 2018 The Court of Justice of the European Union ("CJEU") delivered its judgment in Case C-329/16 Syndicat national de I'industrie de technologies médicales…

Tasmina Goraya, Mathias Kuhn